These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

633 related articles for article (PubMed ID: 24856296)

  • 1. Serum metabolic profiling study of lung cancer using ultra high performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
    Li Y; Song X; Zhao X; Zou L; Xu G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 966():147-53. PubMed ID: 24856296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global metabolic profiling using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
    Qi Y; Song Y; Gu H; Fan G; Chai Y
    Methods Mol Biol; 2014; 1198():15-27. PubMed ID: 25270920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary metabolomic study of non-small cell lung carcinoma based on ultra high performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.
    Wu Q; Wang Y; Gu X; Zhou J; Zhang H; Lv W; Chen Z; Yan C
    J Sep Sci; 2014 Jul; 37(14):1728-35. PubMed ID: 24771673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput ultra-performance liquid chromatography-mass spectrometry characterization of metabolites guided by a bioinformatics program.
    Zhang AH; Wang P; Sun H; Yan GL; Han Y; Wang XJ
    Mol Biosyst; 2013 Sep; 9(9):2259-65. PubMed ID: 23821129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomic profiling of rat serum associated with isoproterenol-induced myocardial infarction using ultra-performance liquid chromatography/time-of-flight mass spectrometry and multivariate analysis.
    Zhang HY; Chen X; Hu P; Liang QL; Liang XP; Wang YM; Luo GA
    Talanta; 2009 Jul; 79(2):254-9. PubMed ID: 19559874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrimination between malignant and benign ovarian tumors by plasma metabolomic profiling using ultra performance liquid chromatography/mass spectrometry.
    Zhang T; Wu X; Yin M; Fan L; Zhang H; Zhao F; Zhang W; Ke C; Zhang G; Hou Y; Zhou X; Lou G; Li K
    Clin Chim Acta; 2012 May; 413(9-10):861-8. PubMed ID: 22309680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomic study of corticosterone-induced cytotoxicity in PC12 cells by ultra performance liquid chromatography-quadrupole/time-of-flight mass spectrometry.
    Zhang H; Zheng H; Zhao G; Tang C; Lu S; Cheng B; Wu F; Wei J; Liang Y; Ruan J; Song H; Su Z
    Mol Biosyst; 2016 Mar; 12(3):902-13. PubMed ID: 26775910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabonomic profiles discriminate hepatocellular carcinoma from liver cirrhosis by ultraperformance liquid chromatography-mass spectrometry.
    Wang B; Chen D; Chen Y; Hu Z; Cao M; Xie Q; Chen Y; Xu J; Zheng S; Li L
    J Proteome Res; 2012 Feb; 11(2):1217-27. PubMed ID: 22200553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal cancer detection using targeted serum metabolic profiling.
    Zhu J; Djukovic D; Deng L; Gu H; Himmati F; Chiorean EG; Raftery D
    J Proteome Res; 2014 Sep; 13(9):4120-30. PubMed ID: 25126899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarker discovery in biological specimens (plasma, hair, liver and kidney) of diabetic mice based upon metabolite profiling using ultra-performance liquid chromatography with electrospray ionization time-of-flight mass spectrometry.
    Tsutsui H; Maeda T; Min JZ; Inagaki S; Higashi T; Kagawa Y; Toyo'oka T
    Clin Chim Acta; 2011 May; 412(11-12):861-72. PubMed ID: 21185819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploratory investigation of plasma metabolomics in human lung adenocarcinoma.
    Wen T; Gao L; Wen Z; Wu C; Tan CS; Toh WZ; Ong CN
    Mol Biosyst; 2013 Sep; 9(9):2370-8. PubMed ID: 23857124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic profiling of plasma in overweight/obese and lean men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC-Q-TOF MS).
    Kim JY; Park JY; Kim OY; Ham BM; Kim HJ; Kwon DY; Jang Y; Lee JH
    J Proteome Res; 2010 Sep; 9(9):4368-75. PubMed ID: 20560578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Joint MS-based platforms for comprehensive comparison of rat plasma and serum metabolic profiling.
    Lin Z; Zhang Z; Lu H; Jin Y; Yi L; Liang Y
    Biomed Chromatogr; 2014 Sep; 28(9):1235-45. PubMed ID: 24619916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urine metabolic fingerprinting using LC-MS and GC-MS reveals metabolite changes in prostate cancer: A pilot study.
    Struck-Lewicka W; Kordalewska M; Bujak R; Yumba Mpanga A; Markuszewski M; Jacyna J; Matuszewski M; Kaliszan R; Markuszewski MJ
    J Pharm Biomed Anal; 2015; 111():351-61. PubMed ID: 25684700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomic profiling of human serum in lung cancer patients using liquid chromatography/hybrid quadrupole time-of-flight mass spectrometry and gas chromatography/mass spectrometry.
    Chen Y; Ma Z; Li A; Li H; Wang B; Zhong J; Min L; Dai L
    J Cancer Res Clin Oncol; 2015 Apr; 141(4):705-18. PubMed ID: 25293627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and validation of plasma biomarkers for major depressive disorder classification based on liquid chromatography-mass spectrometry.
    Liu X; Zheng P; Zhao X; Zhang Y; Hu C; Li J; Zhao J; Zhou J; Xie P; Xu G
    J Proteome Res; 2015 May; 14(5):2322-30. PubMed ID: 25784130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of serum metabolites in gestational diabetes mellitus by UPLC/Q-TOF-MS.
    Liu T; Li J; Xu F; Wang M; Ding S; Xu H; Dong F
    Anal Bioanal Chem; 2016 Feb; 408(4):1125-35. PubMed ID: 26677023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Method for liver tissue metabolic profiling study and its application in type 2 diabetic rats based on ultra performance liquid chromatography-mass spectrometry.
    Huang Q; Yin P; Wang J; Chen J; Kong H; Lu X; Xu G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Apr; 879(13-14):961-7. PubMed ID: 21440515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum.
    Zhang X; Xu L; Shen J; Cao B; Cheng T; Zhao T; Liu X; Zhang H
    Biochim Biophys Acta; 2013 Aug; 1832(8):1207-16. PubMed ID: 23524237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabonomics study of liver cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations.
    Chen J; Wang W; Lv S; Yin P; Zhao X; Lu X; Zhang F; Xu G
    Anal Chim Acta; 2009 Sep; 650(1):3-9. PubMed ID: 19720165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.